Moviprep

Polyethylene glycol 3350 with electrolytes and ascorbic acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is indicated for bowel cleansing in adult patients undergoing colonoscopy, sigmoidoscopy or radiologic examinations, providing rapid and thorough evacuation of the intestinal tract.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed under strict quality controls.

Moviprep, an osmotic laxative, is used for bowel cleansing in gastrointestinal endoscopic and radiologic procedures. - Colonoscopy preparation: provides effective bowel cleansing to enable clear visualization of the colon. - Sigmoidoscopy preparation: clears the distal colon for safe examination. - Radiologic examination preparation: empties the bowel to improve imaging quality.

Moviprep may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal bloating: sensation of fullness or distension. - Abdominal pain or cramps: discomfort in the stomach area. - Vomiting: occasional expulsion of stomach contents.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Renal impairment: reduced kidney function in susceptible individuals.

Before using Moviprep, consider the following precautions to ensure safe and effective bowel preparation. - Assess renal function: evaluate kidney health, especially in patients with known impairment. - Monitor electrolytes: check serum sodium, potassium and chloride levels before and after preparation. - Use with caution in heart failure: fluid shifts may exacerbate congestion. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Ensure adequate fluid intake: patients should drink the recommended amount of clear liquids. - Store at ambient temperature: keep in the original packaging, protect from moisture.

Moviprep can interact with other medicines, affecting fluid and electrolyte balance or bowel motility.

Major Interactions (Avoid): - Concomitant high‑dose diuretics: may cause severe electrolyte disturbances and dehydration. - Use with other osmotic laxatives: can lead to excessive fluid loss and electrolyte imbalance.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment when combined with bowel cleansing. - Anticholinergic agents: may reduce the efficacy of bowel evacuation. - ACE inhibitors or ARBs: can affect potassium levels during preparation. - Oral anticoagulants: monitor for bleeding risk if mucosal irritation occurs.